Skip to main content

Table 2 Clinical response for the 120 patients who received Bravelle® and the 118 patients who received Follistim®.

From: Highly purified human-derived follicle-stimulating hormone (Bravelle®) has equivalent efficacy to follitropin-beta (Follistim ®) in infertile women undergoing in vitro fertilization

Parameter Bravelle® (n = 120) Follistim® (n = 118) P-value
Day 1 of stimulationa    
   Serum FSH (mIU/mL) 4.6+1.7 4.9+2.2 0.155
   Serum LH (mIU/mL) 4.6+2.9 4.6+2.6 0.894
   Serum E2 (pg/mL) 23.7 +11.8 22.6 +10.4 0.442
Mean days of FSH therapy 9.1 ± 1.6 9.2 ± 1.5 0.645
Mean total dose of FSH (IU) 2313.8 ± 837.1 2262.7 ± 736.8 0.613
Mean peak estradiol levels (pg/mL) 1893.4 ± 1154.8 1888.9 ± 1131.9 0.817
  1. Data are means ± SD. There were no significant differences between groups on any parameter. aSerum levels taken on the first day of gonadotropin stimulation.
\